Skip to Main Content

Good morning, everyone, and how are you today? We are doing just fine, thank you, especially now that the middle of the week is here. After all, this means just a few days are left until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we will keep busy brewing another cup of stimulation — mocha nut fudge is our choice today, for no particular reason — and forage for interesting items. Meanwhile, here are some tidbits to get you going. Have a splendid day and we hope you conquer the world. …

Four lawmakers from the Senate and House introduced a bill to prohibit illegal marketing and distribution of opioids; create criminal liability for top company executives; penalize drug makers who illegally advertise, market or distribute an opioid product; and require drug makers to reimburse the country for the negative economic impact of their products. The move comes after former Insys Therapeutics (INSY) executives were convicted of bribing doctors to prescribe an addictive opioid and Rochester Distributor executives were indicted for failing to monitor opioid shipments.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • No, this is not my blog, but may I take issue with this wording in the Novartis piece? “The drug may cost up to $5 million.”
    Uh, no – it can’t “cost” anything like that, as it implies a link to the actual production of same. The ‘usurious charge by NVS may be up to 5 Million USD’ but that will NOT be their cost.”

Comments are closed.